Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlobalData Plc
  6. News
  7. Summary
    DATA   GB00B87ZTG26


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GlobalData : Plaque psoriasis population to reach over 16.8 million by 2030 in the 7MM influenced by obesity, type 2 diabetes and smoking, says GlobalData

10/13/2021 | 04:12pm EST
13 Oct 2021
Plaque psoriasis population to reach over 16.8 million by 2030 in the 7MM influenced by obesity, type 2 diabetes and smoking, says GlobalData
Posted in Pharma

The number of individuals with diagnosed plaque psoriasis in the seven major markets (7MM*) is projected to increase from around 15,720,000 in 2020 to over 16,850,000 in 2030, at an annual growth rate (AGR) of 0.72% according to GlobalData, a leading data and analytics company. These increases are likely to subsequently increase the size of these markets throughout the forecast period.

The company's latest report, "Plaque Psoriasis - Epidemiology Forecast to 2030", reveals that the prevalence of risk factors such as obesity, type 2 diabetes, and smoking may have an influence on case numbers with estimates that the US will have the highest number of lifetime diagnosed prevalent cases of plaque psoriasis across the 7MM in 2030, with over 8.1 million cases, while Japan will have the lowest, with about 0.47 million. In the **5EU, GlobalData estimates 8.2 million plaque psoriasis diagnoses in 2030.

Walter Gabriel, MPH, Epidemiologist at GlobalData, says: "The rising number of plaque psoriasis cases will be influenced by anticipated population changes over the next decade. For example, psoriasis' higher incidence in older patients will mean that the number of cases in the US will rise from over 7.4 million cases in 2020 to over in 8.1 million cases as the population grows and the number of elderly increases - even though the proportion of people with the disease in the country will remain roughly the same."

Treatments to alleviate the symptoms of plaque psoriasis are widely available, but which type of treatment is required depends on a mixture of symptom severity and a patient's response to previous treatments. Not only that, but these severities and reactions can vary across countries. As a result, understanding the breakdown of the number of patients expected to have mild, moderate and severe psoriasis is critical to treating patients properly.

Gabriel adds: "GlobalData epidemiologists do not expect any significant changes that would alter the size of the plaque psoriasis population at this time."

*7MM: The US, 5EU, and Japan
** 5EU: France, Germany, Italy, Spain and the UK


GlobalData plc published this content on 13 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 October 2021 20:11:25 UTC.

ę Publicnow 2021
All news about GLOBALDATA PLC
11/23Amazon's Visa block called out as tactic to promote Mastercard
11/18GLOBALDATA : Global deal activity down by 5.7% in October 2021, finds GlobalData
11/18GLOBALDATA : AMETEK's job adverts double in 2021 as it prepares to expand into new markets..
11/18Slovenia could become the adventure tourism capital of Europe, says GlobalData
11/18GLOBALDATA : Thailand's hot drinks sector to reach US$2.2bn by 2025, says GlobalData
11/18GLOBALDATA : South Korean hot drinks market to reach US$3bn by 2025, forecasts GlobalData
11/18GLOBALDATA : Hot drinks sector of Philippines to reach US$2.4bn by 2025, forecasts GlobalD..
11/18GLOBALDATA : Psilocybin has potential to become a breakthrough therapy for treatment-resis..
11/18GLOBALDATA : Hot drinks market of Malaysia to reach US$2bn by 2025, says GlobalData
11/18GLOBALDATA : Indonesia's hot drinks market to reach US$3.1bn by 2025, forecasts GlobalData
More news
Sales 2021 190 M 253 M 253 M
Net income 2021 26,3 M 35,0 M 35,0 M
Net Debt 2021 64,8 M 86,4 M 86,4 M
P/E ratio 2021 69,2x
Yield 2021 1,39%
Capitalization 1 610 M 2 145 M 2 147 M
EV / Sales 2021 8,83x
EV / Sales 2022 8,10x
Nbr of Employees 3 472
Free-Float 30,8%
Duration : Period :
GlobalData Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBALDATA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 4
Last Close Price 1 365,00 GBX
Average target price 1 735,00 GBX
Spread / Average Target 27,1%
EPS Revisions
Managers and Directors
Michael Thomas Danson Chief Executive Officer & Director
Sally Kate Miranda Johnson Chief Financial Officer
Murray Legg Independent Non-Executive Chairman
Peter Martin Harkness Independent Non-Executive Director
Catherine Birkett Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
S&P GLOBAL INC.38.27%109 485
RELX PLC28.81%59 299
MSCI INC.39.08%51 203
EQUIFAX INC.44.03%33 885